Table 2.
Effects of antidepressants in patients with epilepsy
Study group | Antidepressants | Follow up | Seizure frequency in treatment group | Reference |
---|---|---|---|---|
9 PWE | FLX | 3 months | 4 Px increase in seizure frequency by >50%; 5 Px not increased | Gigli et al. (1994) |
36 PWE and MDD | SRT, FLX | 1 year | 2 Px increase in seizure frequency; 34 Px not increased (number of Px with reduced seizures not mentioned) | Thome-Souza et al. (2007) |
100 PWE and depression or OCD | SRT | 1 year | 6 Px increase in seizure frequency; 94 Px not increased (number of Px with reduced seizures not mentioned) | Kanner et al. (2000) |
39 PWE and depression | CIT | 4 months | 2 Px had 50% increase in seizures; 37 Px with 50% decrease in seizures | Specchio et al. (2004) |
11 PWE | CIT | 8–10 months | All Px showed improvements: 64.1% mean reduction in seizure frequency | Favale et al. (2003) |
17 PWE | FLX | 14 months | Seizures disappeared in 6 Px; in others, seizure frequency reduced by 30% | Favale et al. (1995) |
43 PWE and HAMD score >15 | CIT | 2 months | No change in seizure frequency | Hovorka et al. (2000) |
75 PWE and HAMD score >15 | MIR, CIT, REB | 7.5 months | No change in seizure frequency | Kuhn et al. (2003) |
28 PWE | FLV | 29–444 days | No change in seizure frequency | Harmant et al. (1990) |
121 PWE | Various 1st and 2nd gen. drugs | 1 year | No change in seizure frequency compared to non-treated Px | Okazaki et al. (2011) |
Patient drop outs not included in sample sizes.
CIT, citalopram; FLV, fluvoxamine; FLX, fluoxetine; HAMD, hamilton depression rating scale; MDD, major depressive disorder; MIR, mirtazepine; OCD, obsessive compulsive disorder; PWE, people with epilepsy; Px, patients; REB, reboxetine; SRT, sertraline.